BindingDB logo
myBDB logout

15 articles for Chugai Pharmaceutical Co., Ltd


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
27189888 Optimization of the phenylurea moiety in a phosphoinositide 3-kinase (PI3K) inhibitor to improve water solubility and the PK profile by introducing a solubilizing group and ortho substituents. 09-JUN-2016 13-SEP-2017
24157370 The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors. 01-NOV-2013 25-JUL-2014
23265889 Lead optimization of a dihydropyrrolopyrimidine inhibitor against phosphoinositide 3-kinase (PI3K) to improve the phenol glucuronic acid conjugation. 14-JAN-2013 24-SEP-2013
23122816 Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors. 26-NOV-2012 17-MAY-2013
21050768 Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer. 12-NOV-2010 03-JAN-2013
20381361 Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists. 30-APR-2010 30-DEC-2012
17064916 Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships. 20-NOV-2006 10-DEC-2012
22192591 Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors. 13-JAN-2012 22-JUL-2012
22225917 Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). 26-JAN-2012 22-JUL-2012
21875802 Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design. 12-SEP-2011 24-MAR-2012
21873071 5a-Carba-ß-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. 12-SEP-2011 23-MAR-2012
21316229 Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. 07-MAR-2011 24-AUG-2011
21316218 Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. 07-MAR-2011 24-AUG-2011
18674905 Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination. 11-AUG-2008 11-JAN-2010
19254843 Synthesis of new camptothecin analogs with improved antitumor activities. 16-MAR-2009 11-JAN-2010